Assistant for high-intensity focusing ultrasonic therapy and its screening method
A focused ultrasound, high-intensity technology, applied in the fields of medicine, medical treatment, and ultrasound therapy, it can solve the problems of decreased treatment efficiency, prolonged treatment time, burns, etc., and achieve the effects of improving damage effect, increasing energy deposition, and enhancing absorption characteristics.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment I
[0035] The preparation of embodiment 1 HIFU therapy microparticles auxiliary agent
[0036] The encapsulated liquid of embodiment I-1 does not produce liquid / gas phase transition at 38~100°C
Embodiment I-1-1
[0038] Weigh respectively 4 g of iodized oil for injection (purchased from Shanghai Chemical Reagent Company), 0.6 g of egg yolk lecithin for injection (purchased from Shanghai Chemical Reagent Company), 1.25 g of glycerin for injection (purchased from Shanghai Chemical Reagent Company), mix and heat Dissolve it at 70° C. to form an oil phase, add distilled water containing 1% (W / V) emulsifier F-68 (purchased from Sigma) to the oil phase to 17.5 ml, form colostrum after vigorous shaking. Put the above-mentioned colostrum in a large test tube, ultrasonically emulsify the colostrum for 2 minutes at a power of 350W to form a uniform emulsified lipiodol, and then sterilize it by circulating steam at 100°C for 30 minutes. The pH value is 7.5-8.5 and contains iodine. Amount 0.13g / ml. Particle size <1μm, osmotic pressure 350mosm / kg water.
Embodiment I-1-2~ Embodiment I-1-4
[0040] According to the same method and steps described in Example I-1-1, use soybean oil for injection instead of iodized oil for injection as core material, use lecithin for injection instead of egg yolk lecithin as film-forming material, according to the following table 1 The listed ratios obtain the following particulate adjuvants for HIFU therapy of the present invention. The obtained adjuvant is a white milky liquid, which is suitable for intravenous injection of animals and humans, and the corresponding parameters are shown in Table 1 below:
[0041]
[0042] The wrapped liquid of embodiment I-2 produces liquid / gas phase transition at 38~100°C
PUM
Property | Measurement | Unit |
---|---|---|
particle diameter | aaaaa | aaaaa |
particle diameter | aaaaa | aaaaa |
particle diameter | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com